235 related articles for article (PubMed ID: 1577392)
21. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
22. Powerful gastric acid inhibition: when is it justified?
Dobrilla G; Amplatz S
Ital J Gastroenterol; 1990; 22 Suppl 1():13-7. PubMed ID: 1983420
[TBL] [Abstract][Full Text] [Related]
23. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
Ladas SD; Tassios PS; Raptis SA
Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
[TBL] [Abstract][Full Text] [Related]
24. Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
[TBL] [Abstract][Full Text] [Related]
25. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
27. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility and safety of omeprazole.
Walan A
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
[TBL] [Abstract][Full Text] [Related]
29. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
[TBL] [Abstract][Full Text] [Related]
30. Medical treatment of gastroesophageal reflux disease: options and priorities.
Thomson AB
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
[TBL] [Abstract][Full Text] [Related]
31. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
[TBL] [Abstract][Full Text] [Related]
32. [Long-term results of conservative management of reflux esophagitis].
Viani F; Dorta G
Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
[TBL] [Abstract][Full Text] [Related]
33. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
Díaz de Rojas F; Ponce García J
An Med Interna; 1992 Sep; 9(9):450-4. PubMed ID: 1391583
[TBL] [Abstract][Full Text] [Related]
34. A review of omeprazole use in the treatment of acid-related disorders in children.
Zimmermann AE; Walters JK; Katona BG; Souney PE; Levine D
Clin Ther; 2001 May; 23(5):660-79; discussion 645. PubMed ID: 11394727
[TBL] [Abstract][Full Text] [Related]
35. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
36. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
[TBL] [Abstract][Full Text] [Related]
37. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
38. Omeprazole in the short-term treatment of reflux oesophagitis.
Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():40-6. PubMed ID: 2691310
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
[TBL] [Abstract][Full Text] [Related]
40. Current trends in the pharmacotherapy for gastroesophageal reflux disease.
Hixson LJ; Kelley CL; Jones WN; Tuohy CD
Arch Intern Med; 1992 Apr; 152(4):717-23. PubMed ID: 1558428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
